Introduction
============

Acute kidney injury (AKI), previously termed as acute renal failure (ARF), is a common acute syndrome characterized by sudden impairment in renal function (RF) caused by a decrease in the glomerular filtration rate (GFR).[@b1-cia-12-153] Although studies have suggested that the elderly population, particularly among males, is more prone to AKI than younger patients,[@b2-cia-12-153] few studies have specifically focused on elderly population with AKI.

Patients with AKI are at increased risk for death and chronic kidney disease (CKD).[@b3-cia-12-153]--[@b6-cia-12-153] Thus, when evaluating the short- and long-term outcomes of AKI, not only the survival but also the recovery of RF is an important clinical issue. However, focusing on the long-term RF outcomes of geriatric AKI individuals may often be difficult because the prognosis is significantly poor following hospital discharge, and survivors are often left with multiple chronic conditions.[@b3-cia-12-153],[@b7-cia-12-153] Since long-term survival rates may be reduced significantly, short-term consequences, such as mortality and RF outcome, may be more important and practical.

The rate of RF recovery post-AKI varies in the literature, possibly due to the lack of a consistent definition of what constitutes renal recovery.[@b8-cia-12-153],[@b9-cia-12-153] Previous studies on recovery from AKI-induced RF have focused on clinical outcomes often assessed at the time of hospital discharge,[@b3-cia-12-153],[@b10-cia-12-153]--[@b13-cia-12-153] and they defined RF recovery as the weaning of the patient from dialysis or a decrease in serum creatinine (SCr) levels below a defined threshold.[@b3-cia-12-153],[@b10-cia-12-153],[@b12-cia-12-153]--[@b15-cia-12-153] The prevalence of post-AKI renal recovery in these available studies has varied widely between 33% and 86%.[@b3-cia-12-153],[@b11-cia-12-153],[@b12-cia-12-153],[@b14-cia-12-153],[@b15-cia-12-153] However, various chronic conditions, refractory pulmonary infection, and the necessity of prolonged mechanical ventilation (MV) can often extend the hospital stays of the elderly. Thus, evaluation of RF recovery and mortality only from the time of hospital discharge is inappropriate, particularly for patients older than 75 years. There are still only a few studies that have reported RF outcome according to AKI severity,[@b12-cia-12-153],[@b15-cia-12-153] and none of these studies used the 2012 Kidney Disease Improving Global Outcomes (KDIGO) criteria to both diagnose AKI and assess recovery.[@b1-cia-12-153]

The objectives of this study were to, 1) compare the rates of complete recovery or nonrecovery from different stages of AKI, as defined by the KDIGO criteria; 2) examine the effect of AKI on short-term RF outcomes and mortality; and 3) identify the rate of recovery from RF at 90 days post-AKI and its risk factors.

Patients and methods
====================

This was a retrospective cohort study performed in the Geriatric Department of the Chinese PLA General Hospital. We collected data of very elderly patients (≥75 years of age) who were treated from January 1, 2007, to December 31, 2015. All patients who developed AKI were enrolled. The study design was approved by the Clinical Ethics Committee of the Chinese PLA General Hospital, and each patient provided written informed consent. Patients were divided into groups of survivors or nonsurvivors based on their survival status at 90 days. Survivors were further divided into recovery and nonrecovery groups based on their RF at 90 days post-AKI. To assess the risk factors of prognosis, we separated the patients into 2 groups based on whether they progressed to nonrecovery or died.

AKI was diagnosed with reference (exclusively) to the patient's SCr level, specifically, by an SCr increase of ≥0.3 mg/dL (≥26.5 µmol/L) within 48 h, or a ≥1.5-fold increase relative to the baseline value, known or presumed to have developed within the prior 7 days.[@b1-cia-12-153] The severity of AKI was defined by the KDIGO staging criteria. Estimated GFRs (eGFRs) were calculated by the Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI).[@b16-cia-12-153]

We noted the age and gender of patients, body mass index (BMI), comorbidities (history of hypertension, coronary disease, COPD, and diabetes mellitus), time from AKI to diagnosis, etiology of AKI (infection, hypovolemia, cardiovascular events, nephrotoxic drugs, surgery, or uncertain), need for dialysis, need for MV, urine output, and mean aortic pressure (MAP). Other laboratory data of interest included baseline SCr, SCr at diagnosis of AKI, peak SCr, blood urea nitrogen (BUN), uric acid, serum prealbumin, albumin, kalemia, serum calcium, serum magnesium, serum phosphate, and hemoglobin.

The baseline SCr level was the most recent stable measure obtained 1--3 months prior to admission with AKI.[@b17-cia-12-153],[@b18-cia-12-153] Peak SCr was the highest SCr reached during the episode. The outcome of RF at 90 days post-AKI as indicated by the eGFR was characterized as recovered (eGFR ≥60 mL/min/1.73 m^2^) or nonrecovered (eGFR \<60 mL/min/1.73 m^2^).[@b19-cia-12-153],[@b20-cia-12-153] Oliguria was defined as urinary output \<400 mL/24 h.

We excluded patients younger than 75 years, previously diagnosed with CKD,[@b19-cia-12-153] stayed in the hospital for \<48 h, had only 1 SCr or no SCr examination, had a missing or incomplete medical history, and who died within 48 h of hospital admission.

Statistical analysis
====================

Continuous variables are presented as mean ± SD values or median (25%--75% interquartile range), depending on the variable distribution. Discrete variables are presented as counts or percentages. Statistical analyses were performed using SPSS version 17.0 for Windows (SPSS Inc., Chicago, IL, USA). Between-group comparisons were made using Student's *t*-test or Mann--Whitney *U* test. Correlations between potential risk factors and renal outcome were assessed using Pearson's chi-squared or Fisher's exact tests. Multivariable logistic regression analyses were performed to identify covariates associated with nonrecovery from AKI. A *P*-value \<0.05 indicated statistical significance.

Results
=======

Baseline characteristics of the enrolled patients
-------------------------------------------------

A total of 3,464 patients were admitted to the Geriatric Department during the study period, and 668 were identified as having AKI. Of these, 16 were excluded for the reasons shown in [Figure 1](#f1-cia-12-153){ref-type="fig"}, resulting in 652 patients with AKI suitable for analysis. On day 28 after AKI, 481 patients (73.8%) were alive, and 171 patients (26.2%) were deceased. In all, 219 patients (33.6%) died within 90 days. Of the 433 survivors with AKI in whom recovery could be assessed, 316 patients (73.0%) recovered to their baseline eGFR, and 117 patients (27.0%) developed CKD. Death or no recovery occurred in 336 (51.5%) patients.

Demographic characteristics of elderly patients with AKI
--------------------------------------------------------

Baseline characteristics of 652 elderly patients with AKI are shown in [Table 1](#t1-cia-12-153){ref-type="table"}. The median age of the cohort was 87 years, with 95.6% being male. The median baseline eGFR was 78.4 mL/min/1.73 m^2^. Using the KDIGO criteria, 308 patients (47.2%) were classified as stage 1 AKI, 164 (25.2%) as stage 2, and 180 (27.6%) as stage 3. The most common comorbid conditions were coronary disease (505, 77.5%), hypertension (485, 74.4%), COPD (454, 69.6%), and diabetes mellitus (234, 35.8%). Overall, 240 patients (36.8%) required MV, 35 (5.4%) had oliguria, and 9 (1.4%) of stage 3 patients required acute dialysis.

The relationship of AKI etiology with 90-day mortality and RF outcomes
----------------------------------------------------------------------

The most frequent causes of AKI in geriatric patients were infection (259, 39.7%), hypovolemia (155, 23.8%; volume depletion or hypotension), cardiovascular events (103, 15.8%; acute coronary syndrome or acute heart failure), nephrotoxicity (78, 12.0%), surgery (45, 6.9%), and others (12, 1.8%).

Examination of the difference in prevalence of the most common AKI relative to mortality and RF outcome is shown in [Table 2](#t2-cia-12-153){ref-type="table"}. There was no significant association between the recovery group and the nonrecovery group regarding AKI etiology (all *P*\>0.05). Nonsurvivors were more likely to have had infections and less nephrotoxic drugs upon AKI diagnosis than were survivors (53.0% vs 33.0%, *P*\<0.001; 5.5% vs 15.2%, *P*=0.001).

Clinical characteristics and 90-day mortality and RF outcomes
-------------------------------------------------------------

At 90 days, survivors had 73.0% complete recovery and 27.0% did not recover. The prevalence rates of eGFR levels of ≥90 mL/min/1.73 m^2^, 60--89 mL/min/1.73 m^2^, 45--59 mL/min/1.73 m^2^, 30--44 mL/min/1.73 m^2^, 15--29 mL/min/1.73 m^2^, and \<15 mL/min/1.73 m^2^ were 8.3%, 64.7%, 18.2%, 6.2%, 2.1%, and 0.5%, respectively ([Figure 2](#f2-cia-12-153){ref-type="fig"}).

As shown in [Table 3](#t3-cia-12-153){ref-type="table"}, no significant difference was evident between the 2 cohorts in terms of comorbidities (coronary disease *P*=0.613, hypertension *P*=0.212, COPD *P*=0.397 and diabetes mellitus *P*=0.711). Likewise, no differences were found in age (*P*=0.878) and gender (*P*=0.636). BMI (22.7±3.0 vs 23.4±3.3, *P*=0.002) and baseline eGFR (79.2 mL/min/1.73 m^2^ vs 78.0 mL/min/1.73 m^2^, *P*\<0.001) differed significantly between the 2 groups.

Upon comparing the 2 groups shown in [Table 3](#t3-cia-12-153){ref-type="table"}, we found that patients with nonrecovery and death had higher SCr (137.6 µmol/L vs 125.0 µmol/L, *P*\<0.001) and peak SCr (173.3 µmol/L vs 129.8 µmol/L, *P*\<0.001) levels, as well as a higher BUN (17.0 mmol/L vs 11.0 mmol/L, *P*\<0.001) level compared with patients with renal recovery at the time of AKI diagnosis. Of the 336 patients who did not recover, AKI diagnosis occurred 2.0 days (2.0--6.0 days) compared to 3.0 days (2.0--7.0 days) with patients with renal recovery (*P*=0.001). Low MAP (75±13 mmHg vs 82±14 mmHg, *P*\<0.001), oliguria (7.7% vs 2.8%, *P*\<0.001), anemia (107±23 g/L vs 118±21 g/L, *P*\<0.001), a lower prealbumin level (164 g/L vs 198 g/L, *P*\<0.001), hypoalbuminemia (32.9±5.5 g/L vs 35.9±5.0 g/L, *P*\<0.001), higher uric acid (393 µmol/L vs 348.0 µmol/L, *P*\<0.001) level, magnesium (0.9 mmol/L vs 0.9 mmol/L, *P*=0.028) level, and phosphate (1.2 mmol/L vs 1.2 mmol/L, *P*=0.001) level were more frequent among patients who did not recover from RF.

RF outcomes and mortality according to AKI severity
---------------------------------------------------

As expected, full recovery among survivors decreased substantially with increasing AKI severity (from 67.1% in stage 1 to 10.4% in stage 3; *P*\<0.001; [Figure 3](#f3-cia-12-153){ref-type="fig"}).

Risk factors for 90-day outcomes in geriatric patients with AKI
---------------------------------------------------------------

In the multivariate Cox regression analysis, BMI (hazard ratio \[HR\] =0.956, 95% CI: 0.923--0.990, *P*=0.011), baseline eGFR (HR =0.981, 95% CI: 0.968--0.993, *P*=0.002), low MAP (HR =0.980, 95% CI: 0.972--0.988, *P*\<0.001), low prealbumin level (HR =0.975, 95% CI: 0.955--0.995, *P*=0.015), hypoalbuminemia (HR =0.975, 95% CI: 0.952--0.999, *P*=0.042), oliguria (HR =2.007, 95% CI: 1.332--3.025, *P*=0.001), BUN level (HR =1.028, 95% CI: 1.018--1.038, *P*\<0.001), and more severe AKI stage (stage 2: HR =1.932, 95% CI: 1.424--2.621, *P*\<0.001; stage 3: HR =3.831, 95% CI: 2.786--5.270, *P*\<0.001) were independent risk factors for 90-day poor outcomes after AKI development ([Table 4](#t4-cia-12-153){ref-type="table"}).

Discussion
==========

As results of the present study indicate, in a very elderly population, aged 75 years and older, up to 27% of AKI survivors developed CKD stage 3--5, during a 90-day follow-up period. To the best of our knowledge, no previous research has evaluated short-term mortality and RF outcome after AKI in very elderly patients, particularly using the complete standardized KDIGO criteria.

In the very elderly, the development of clinically relevant AKI is associated with age-dependent changes, which are independent risk factors for AKI. Such changes render older patients more prone to medication-associated toxicities and ischemic injury. Furthermore, elderly individuals are very vulnerable to coexisting illness and are more likely to require surgery. Often, multidrug combination therapy is required; this is a prime trigger of AKI. In the present study, multivariable Cox regression analysis showed that the etiology of AKI was not a risk factor for 90-day RF nonrecovery.

Most clinical studies of RF recovery from AKI usually evaluated outcome at hospital discharge, and the most frequent outcome definitions were limited to the necessity of dialysis. Few studies have evaluated the recovery from less severe forms of AKI. They used return-to-baseline SCr,[@b12-cia-12-153],[@b21-cia-12-153] normalization of SCr,[@b3-cia-12-153] return-to-baseline eGFR,[@b22-cia-12-153] or absence of AKI criteria at discharge,[@b23-cia-12-153] all based on comparisons of discharge SCr, or the derived eGFR, with baseline SCr or eGFR. These criteria are associated with different rates of renal recovery depending on the study being evaluated. Ali et al published a study with 474 patients with AKI using Risk, Injury, Failure, Loss and End-stage Kidney Disease (RIFLE) definition.[@b21-cia-12-153] They reported that among those patients with normal RF before AKI, 92% had a complete RF recovery (SCr returned to baseline value), 7% had partial recovery (normalization of SCr), and only 0.6% had no recovery (remained on dialysis for \>3 months after discharge). Pannu et al,[@b3-cia-12-153] in a population-based cohort, found a 70% recovery rate (defined as SCr within 25% of their baseline at 90 days after discharge) and 30% nonrecovery rate. In a retrospective observational study, Thongprayoon et al[@b24-cia-12-153] reported a 34% renal recovery (independence from dialysis by 90 days) rate in post-cardiac surgery patients who required dialysis. However, studies that consider renal recovery as independence from dialysis can show higher recovery rates than those that evaluate patients with AKI based on baseline SCr.[@b25-cia-12-153] Additionally, studies using a discharge SCr to assess renal outcome in elderly patients with AKI can overestimate the incidence of renal recovery.[@b26-cia-12-153] We used a very restrictive definition of renal recovery (ie, return to eGFR ≥60 mL/min/1.73 m^2^ rather than to SCr), because using eGFR enabled us to classify the patients according to their KDIGO stage of chronic disease. Applying such a definition, we found that 73% of our AKI survivors had a complete recovery at 90 days.

Another important issue is determining at what point renal recovery must be evaluated, ie, at hospital discharge, after 28 days, after 90 days, etc. In our study, evaluation of RF outcome was performed 90 days after an AKI episode according to the KDIGO AKI guidelines.[@b1-cia-12-153] We did not use hospital discharge as a time point to assess recovery. Because various chronic conditions in the very elderly often extend the hospital stays, hospital discharge might not be an optimal time point at which to assess AKI recovery. In addition, CKD is defined as eGFR \<60 mL/min/1.73 m^2^ for ≥3 months; hence, assessing RF at 90 days can best describe the incidence of CKD.

It is important to identify the predictors associated with death or renal nonrecovery. Our analysis suggests that BMI, baseline eGFR, low MAP, low prealbumin level, hypoalbuminemia, oliguria, BUN level, and more severe AKI stage were independent risk factors associated with death or renal nonrecovery. Other studies have identified advanced age, preexisting diabetes mellitus, decreased baseline eGFR,[@b27-cia-12-153] higher Charlson comorbidity index score,[@b28-cia-12-153] or hypomagnesemia[@b23-cia-12-153] as risk factors for renal nonrecovery in AKI survivors. Following a community-based study of patients older than 65 years, Sesso et al found a relationship between the rate of decline in eGFR with age and baseline eGFR, a result similar to that observed by Collins et al.[@b29-cia-12-153],[@b30-cia-12-153] In contrast, Schiffl did not find any prognostic indicators related to partial recovery (defined as SCr \>115 µmol/L at hospital discharge) when analyzing 226 critically ill patients with previous normal RF who had AKI requiring dialysis.[@b25-cia-12-153] James et al, studying older patients following coronary angiography, observed that the patients who developed AKI were more prone to nonrenal recovery beyond 90 days after the angiography and were more likely to progress toward end-stage renal disease (ESRD).[@b31-cia-12-153] These adverse effects were associated with the severity of AKI.[@b26-cia-12-153],[@b31-cia-12-153] In our cohort, however, the peak SCr level and the need for dialysis (both indicative of AKI severity) were not independent factors associated with renal nonrecovery in the multivariate regression.

In the present study, dialysis was performed in only 9 cases (1.4%) during follow-up; 6 patients died within 90 days, and the other 3 became dependent on dialysis during the analysis period. Thus, the results of this study might be indicating a better-than-usual short-term outcome after AKI: only 0.5% of patients progressed to ESRD.

Strengths of this study include the elderly age of the sample, the use of a consensus definition for AKI/CKD diagnosis and stages, and baseline SCr being available in the entire sample of included patients. On the other hand, limitations of this study should be noted. First, this was a single-center retrospective work, so the results may not be immediately applicable to other hospitalized patients. Second, we analyzed data from a veteran's hospital, and most patients were retired elderly males and fewer females are treated in our hospital. Thus, biased results may be unavoidable. Third, the definition of AKI in our analysis was based on SCr levels. We chose not to use the urine output criteria because these data were incomplete. Fourth, the number of female patients in all AKI groups and the need for dialysis were too small to determine the role in RF outcomes.

Conclusion
==========

BMI, baseline eGFR, low MAP, low prealbumin level, hypoalbuminemia, oliguria, BUN level, and more severe AKI stage are significant high risk prognostic factors for poor outcome of RF in very elderly patients with AKI. Identification of these factors might lead to more intensive monitoring and early prevention and could improve outcomes for very elderly patients with AKI.
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![Flow chart of patient inclusion and exclusion.\
**Abbreviations:** AKI, acute kidney injury; CKD, chronic kidney disease; SCr, serum creatinine.](cia-12-153Fig1){#f1-cia-12-153}

![Evolution of renal function according to KDIGO staging.\
**Notes:** G1: ≥90 mL/min/1.73 m^2^; G2: 60--89 mL/min/1.73 m^2^; G3a: 45--59 mL/min/1.73 m^2^; G3b: 30--44 mL/min/1.73 m^2^; G4: 15--29 mL/min/1.73 m^2^; and G5: \<15 mL/min/1.73 m^2^.\
**Abbreviations:** KDIGO, Kidney Disease Improving Global Outcomes; G, glomerular filtration rate category.](cia-12-153Fig2){#f2-cia-12-153}

![Renal function outcomes and mortality of different AKI stages in patients with AKI.\
**Abbreviation:** AKI, acute kidney injury.](cia-12-153Fig3){#f3-cia-12-153}

###### 

Summary of participant characteristics

  Characteristics                             Values
  ------------------------------------------- -------------------
  Age (years)                                 87 (84--91)
  BMI (kg/m^2^)                               23.1±3.2
  Comorbidity                                 
   Coronary disease                           505 (77.5)
   Hypertension                               485 (74.4)
   COPD                                       454 (69.6)
   Diabetes                                   234 (35.8)
  Baseline eGFR (mL/min/1.73 m^2^)            78.4 (71.2--85.0)
  Etiology of AKI                             
   Infections                                 259 (39.7)
   Hypovolemia                                155 (23.8)
   Cardiovascular events                      103 (15.8)
   Nephrotoxicity                             78 (12.0)
   Surgery                                    45 (6.9)
   Others                                     12 (1.8)
  Parameter at the time of AKI diagnosis      
   Oliguria                                   35 (5.4)
   Dialysis                                   9 (1.4)
   MV                                         240 (36.8)
  AKI stage                                   
   1                                          308 (47.2)
   2                                          164 (25.2)
   3                                          180 (27.6)
  eGFR 90 days after AKI (mL/min/1.73 m^2^)   72.3 (56.9--83.0)
  Renal function recovery at 90 days          316/433 (73.0)
  90-day mortality                            219/652 (33.6)

**Note:** Values are n (%), mean ± SD, or median (interquartile range).

**Abbreviations:** AKI, acute kidney injury; BMI, body mass index; eGFR, estimated glomerular filtration rate; MV, mechanical ventilation.

###### 

Prevalence of the most common AKI causes relative to mortality and renal function outcomes

  ----------------------------------------------------------------------------------------------------------------------------------
  Characteristics          Nonsurvival group,\   Survival group,\   *P*-value   Nonrecovery group,\   Recovery group,\   *P*-value
                           n=219 (33.6)          n=433 (66.4)                   n=117 (27.0)          n=316 (73.0)       
  ------------------------ --------------------- ------------------ ----------- --------------------- ------------------ -----------
  Etiology of AKI                                                                                                        

   Infection               116 (53.0)            143 (33.0)         \<0.001     34 (29.1)             109 (34.5)         0.286

   Hypovolemia             53 (24.2)             102 (23.6)         0.621       29 (24.8)             73 (23.1)          0.714

   Cardiovascular events   27 (12.3)             76 (17.6)          0.088       20 (17.1)             56 (17.7)          0.879

   Nephrotoxicity          12 (5.5)              66 (15.2)          0.001       20 (17.1)             46 (14.6)          0.514

   Surgery                 9 (4.1)               36 (8.3)           0.058       11 (9.4)              25 (7.9)           0.618

   Others                  2 (0.9)               10 (2.3)           0.251       3 (2.6)               7 (2.2)            1.000
  ----------------------------------------------------------------------------------------------------------------------------------

**Note:** Values are n (%).

**Abbreviation:** AKI, acute kidney injury.

###### 

Comparisons of clinical characteristics of elderly patients with AKI according to mortality and renal function outcomes

  Characteristics                                   Patients with AKI (n=652)   Nonrecovery and death group, n=336 (51.5)   Recovery group, n=316 (48.5)   *P*-value
  ------------------------------------------------- --------------------------- ------------------------------------------- ------------------------------ -----------
  Age (years)                                       87 (84--91)                 88 (84--91)                                 87 (84--91)                    0.878
  Male                                              623 (95.6)                  321 (95.5)                                  302 (95.6)                     0.636
  BMI (kg/m^2^)                                     23.1±3.2                    22.7±3.0                                    23.4±3.3                       0.002
  Comorbidity                                                                                                                                              
   Coronary disease                                 505 (77.5)                  264 (78.6)                                  241 (76.3)                     0.613
   Hypertension                                     485 (74.4)                  245 (72.9)                                  240 (75.9)                     0.212
   COPD                                             454 (69.6)                  229 (68.2)                                  225 (71.2)                     0.397
   Diabetes                                         234 (35.8)                  115 (34.2)                                  119 (37.7)                     0.711
  Baseline eGFR (mL/min/1.73 m^2^)                  78.4 (71.2--85.0)           79.2 (69.8--86.0)                           78.0 (71.7--83.6)              \<0.001
  Time for AKI to develop (days)                    2.0 (2.0--7.0)              2.0 (2.0--6.0)                              3.0 (2.0--7.0)                 0.001
  Parameter at the time of AKI diagnosis                                                                                                                   
   MAP (mmHg)                                       78±14                       75±13                                       82±14                          \<0.001
   Oliguria                                         35 (5.4)                    26 (7.7)                                    9 (2.8)                        \<0.001
   Dialysis                                         9 (1.4)                     9 (2.7)                                     0                              0.014
   MV                                               240 (36.8)                  162 (48.2)                                  78 (24.7)                      \<0.001
  Laboratory results at the time of AKI diagnosis                                                                                                          
   SCr (µmol/L)                                     131.4 (117.5--147.0)        137.6 (123.0--156.0)                        125.0 (113.7--138.3)           \<0.001
   Peak SCr (µmol/L)                                143.7 (124.0--200.0)        173.3 (138.6--269.4)                        129.8 (116.0--147.9)           \<0.001
   BUN (mmol/L)                                     12.6 (8.8--20.9)            17.0 (9.8--26.6)                            11.0 (8.0--15.6)               \<0.001
   Uric acid (mmol/L)                               364.9 (290.0--467.0)        393.0 (300.2--497.8)                        348.0 (281.3--430.4)           \<0.001
   Prealbumin (g/L)                                 181.0 (140.0--231.0)        164 (126--216)                              198 (156--247)                 \<0.001
   Albumin (g/L)                                    34.3±5.5                    32.9±5.5                                    35.9±5.0                       \<0.001
   Magnesium (mmol/L)                               0.9 (0.8--1.0)              0.9 (0.8--1.0)                              0.9 (0.8--1.0)                 0.028
   Calcium (mmol/L)                                 2.2 (2.1--2.3)              2.2 (2.1--2.3)                              2.2 (2.1--2.4)                 0.431
   Phosphate (mmol/L)                               1.2 (1.0--1.5)              1.2 (1.0--1.5)                              1.2 (0.9--1.4)                 0.001
   Hemoglobin (g/L)                                 112±23                      107±23                                      118±21                         \<0.001

**Notes:** Values are n (%), mean ± SD, or median (interquartile range). 1 mmHg =0.133 kPa.

**Abbreviations:** AKI, acute kidney injury; BMI, body mass index; BUN, blood urea nitrogen; eGFR, estimated glomerular filtration rate; MAP, mean aortic pressure; MV, mechanical ventilation; SCr, serum creatinine.

###### 

Factors associated with 90-day outcomes as indicated by Cox regression

  Risk factors       HR          95% CI         *P*-value
  ------------------ ----------- -------------- -----------
  BMI                0.956       0.923--0.990   0.011
  Baseline eGFR      0.981       0.968--0.993   0.002
  Prealbumin level   0.975       0.955--0.995   0.015
  Albumin            0.975       0.952--0.999   0.042
  MAP                0.980       0.972--0.988   \<0.001
  Oliguria           2.007       1.332--3.025   0.001
  BUN level          1.028       1.018--1.038   \<0.001
  AKI stage                                     \<0.001
   Stage 1           Reference   Reference      
   Stage 2           1.932       1.424--2.621   \<0.001
   Stage 3           3.831       2.786--5.270   \<0.001

**Note:** 1 mmHg =0.133 kPa.

**Abbreviations:** AKI, acute kidney injury; BMI, body mass index; BUN, blood urea nitrogen; eGFR, estimated glomerular filtration rate; HR, hazard ratio; MAP, mean aortic pressure.
